Another shakeout before move up?, page-62

I agree with you, Maurico, the lack of shareholder communication has been the trademark of the company and the this does no good to the share price. Also they appear to be dragging their feet on the partnerships giving the same news on the progress which has become annoying (a cut and paste from previous reports) and rather then pushing the FDA to get the products approval especially since the GVHD 28 days results should have been analysed. If the 28 days results have met the endpoints, the 90 days should not be any different as I am told.
If the analyst say that the 28 day results should be out in end February/ early March, I wonder where they got this news from. Perhaps they are have been playing it safe and giving ample time for the announcement to be made. I have given up contacting the company as they do not even bother to respond or acknowledge the e-mails sent.